(Q44023782)

29 November 2017

title

Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death (English)

1 reference

29 November 2017

Yicheng Zhang

1

1 reference

29 November 2017

Michael Crump

series ordinal

2

1 reference

29 November 2017

Stuart A Berge

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Breast Cancer Research and Treatment

29 November 2017

published in

1 reference

29 November 2017

volume

72

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

265-278

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1014965726663

29 November 2017

exact match

0 references

cites work

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

The status of high-dose chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Basic fibroblast growth factor (bFGF): mitogenic activity and binding sites in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Roles of cytoplasmic Ca2+ and intracellular Ca2+ stores in induction and suppression of apoptosis in S49 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

Clinical multidrug resistance in cancer: a multifactorial problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

On the mechanism of action of econazole, the capacitative calcium inflow blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

[Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: results of the national protocol Pegase 04]

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

Minimal residual disease in autologous hematopoietic harvests from breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1014965726663

7 January 2021

Identifiers

DOI

10.1023/A:1014965726663

1 reference

Dimensions Publication ID

29 November 2017

1024430400

0 references

1 reference